KVUE Stock Price Today (April 2026) — Kenvue Inc. Analysis & Key Metrics 2026-04-15
Kenvue Inc. (KVUE) is trading at $17.46, up 0.46% today (as of April 2026). The stock continues to show mixed signals with a short-term dip within a broader uptrend, attracting attention from investors looking for Consumer Defensive growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $19.83 (13.6% upside).
- Volatility remains elevated (20.46% annualized), implying wide price swings for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: solid revenue growth (3.20% YoY) alongside significant competitive pressures.
KVUE Stock Analysis: Key Metrics & Valuation (April 2026)
Concise, actionable data for investors
Kenvue Inc. - Historical Price & Volume
Market Cap
Enterprise Value: $40.46B
P/E Ratio
Forward P/E: 14.16
Revenue Growth
Year over Year
Analyst Target
+13.6% upside potential
Key Investor Questions About KVUE
What investors need to know before buying
Based on current market data, KVUE presents a neutral technical setup with caution warranted fundamentals.
- Technicals say: Neutral (RSI 46.44)
- Fundamentals say: Caution warranted (high leverage concerns)
KVUE's growth trajectory depends on its ability to expand within the Household & Personal Products sector while managing margin pressures.
- Future growth will depend on performance in core Household & Personal Products operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for KVUE investors include debt exposure and competitive dynamics in the Household & Personal Products industry.
- $8.67B in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Household & Personal Products.
52-Week Trading Range
Over the past year, KVUE stock traded between $14.02 and $25.17—recovering meaningfully from lows and currently near the higher end. Big swings are likely unless a major catalyst emerges.
Volatility & Risk Profile
With 20.46% annualized volatility and β=0.47, the stock exhibits low sensitivity to market moves—making KVUE suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
High institutional backing, but elevated short interest signals a potential battleground stock.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines and coverage
Kimberly-Clark Maps Kenvue Integration As Valuation Suggests Upside Potential
Kimberly-Clark (NasdaqGS:KMB) has outlined its post acquisition organizational structure ahead of integrating Kenvue. The company is forming four regional business segments to manage operations across its expanded global footprint. Chairman and CEO Mike Hsu is set to continue leading the combined organization. Kimberly-Clark, best known for its global personal care and tissue brands, is preparing for a larger role in consumer health and hygiene with the planned integration of Kenvue. The...
Kimberly-Clark keeps Urdaneta as CFO of combined company
The Huggies parent laid out the organizational structure and executive leadership team it will put in place after its $40 billion acquisition of Kenvue closes in the latter half of this year.
Are Options Traders Betting on a Big Move in Kenvue Stock?
Investors need to pay close attention to KVUE stock based on the movements in the options market lately.
Kimberly-Clark's New Structure Sets Stage for Kenvue Integration
Kimberly-Clark's lean new regional structure is built for speed as it prepares to integrate Kenvue in a $48.7B deal closing in H2 2026.
Kimberly-Clark Details Structure, Leadership Team Following Kenvue Deal
The combined company, which will include consumer brands such as Kleenex tissues and Huggies diapers as well as over-the-counter products including Tylenol and Listerine, will operate under four geographic business segments.
Johnson & Johnson Financial Chief Sees ‘Clear Line of Sight’ to Double-Digit Growth by 2030
Johnson & Johnson has reinvented itself several times in recent years. Its latest earnings report signals the company has reinvented itself again. J&J posted adjusted earnings of $2.70 a share for the first quarter, narrowly beating out the $2.68 a share analysts had anticipated.
Jim Cramer Says “I Think at 5.25% Yield, I Want to Own Kimberly-Clark (KMB)”
Kimberly-Clark Corporation (NASDAQ:KMB) is among the stocks Jim Cramer discussed alongside the tech market divide. When a caller inquired about the stock during the episode, Cramer said: Well… Remember, it just had that fire, the six-alarm fire at its largest distribution center of toilet paper. Let’s, you know, Mike Hsu did not necessarily set that […]
Newell Brands Faces Soft Core Sales: Time to Stay Cautious?
NWL faces a tough 2026 start as tariffs pressure sales, but innovation launches and productivity savings are likely to support a gradual recovery.
Boomers and Retirees Are Sticking With 5 of the Highest-Yielding Dividend Kings
Depending on who you ask, there is a chance we will get no interest rate cuts in 2026, or if we do, it’ll be just one. Inflation fueled by higher energy costs, tariffs, and a host of other factors could be the reason the Federal Reserve cites for not lowering rates until those rising costs ... Boomers and Retirees Are Sticking With 5 of the Highest-Yielding Dividend Kings
How Kenvue’s AAD 2026 Sun Care Science Push At Kenvue (KVUE) Has Changed Its Investment Story
At the 2026 American Academy of Dermatology Annual Meeting in Denver, Kenvue’s Neutrogena, Aveeno and Rogaine brands showcased new science-backed skincare and haircare products, 20 research abstracts, and educational initiatives for dermatology professionals, highlighting advances in hydration, acne care, healthy aging and sun protection. A particularly interesting angle for investors is Kenvue’s push to lead US sun care innovation by spotlighting bis-ethylhexyloxyphenol methoxyphenyl...
Frequently Asked Questions
Common investor questions about Kenvue Inc.
Kenvue Inc. (KVUE) is currently trading at $17.46. The RSI (14-day) is at 46.4, indicating neutral territory. Wall Street analysts have a consensus "hold" recommendation. The mean analyst price target of $19.83 implies 13.6% upside from current levels. Volatility is moderate at 20.5% annualized, meaning price movements are relatively contained. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for Kenvue Inc. (KVUE): The trailing P/E ratio is 22.55, which is in line with broader market averages. The forward P/E is 14.16, lower than the trailing P/E, suggesting analysts expect earnings improvement. The PEG ratio is 1.48, near 1.0, suggesting roughly fair value relative to growth. Price-to-Book is 3.05. Price-to-Sales is 2.17. Valuation should be compared to Household & Personal Products industry peers for context, as different sectors trade at different multiples.
Based on 12 analysts covering KVUE, the consensus price target is $19.83. This represents a 13.6% upside from the current price of $17.46. The range spans from a low target of $18.00 to a high target of $23.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "hold". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Yes, Kenvue Inc. (KVUE) pays a dividend with a current yield of approximately 4.75%. The annualized dividend rate is $0.82 per share. The payout ratio is 108.5%, which exceeds 100%—this means the company is paying out more than it earns, which may not be sustainable long-term. The most recent ex-dividend date was 2026-02-11.
Key risks for Kenvue Inc. (KVUE) investors include: 1. Unsustainable dividend payout ratio (109%) could lead to a dividend cut. 2. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 3. Household & Personal Products sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is Kenvue Inc.'s (KVUE) current debt and financial health profile: Total debt stands at $8.67B. The debt-to-equity ratio is 80.58, which is elevated and warrants monitoring, especially in a rising interest rate environment. The current ratio is 0.96, which is below 1.0 and may indicate short-term liquidity concerns. The quick ratio is 0.58. The company holds $1.06B in cash and equivalents. Free cash flow is positive at $1.81B, providing a cushion for debt servicing and shareholder returns.